Sci Transl Med. 2012 Feb 15;4(121):121le1; author reply 121lr1. doi: 10.1126/scitranslmed.3003686.
A recent report from Urano et al. described the development of near-infrared (NIR) probes for cancer detection using chemical bioconjugation of targeting agents. Here, I highlight an alternative strategy to develop cancer-selective NIR imaging and theranostic agents without chemical conjugation.
最近,内浦等人的一份报告描述了使用靶向试剂的化学生物偶联来开发用于癌症检测的近红外(NIR)探针。在这里,我强调一种替代策略,用于开发无需化学偶联的癌症选择性 NIR 成像和治疗诊断试剂。